Target Name: SCN5A
NCBI ID: G6331
Other Name(s): SCN5A variant 2 | PFHB1 | Sodium voltage-gated channel alpha subunit 5, transcript variant 3 | HB1 | IVF | SSS1 | sodium voltage-gated channel alpha subunit 5 | cardiac tetrodotoxin-insensitive voltage-dependent sodium channel alpha subunit | Sodium channel protein type 5 subunit alpha (isoform d) | Sodium channel protein type 5 subunit alpha (isoform f) | Sodium channel, voltage-gated, type V, alpha subunit | SCN5A variant 4 | Sodium channel protein type 5 subunit alpha (isoform b) | Sodium channel protein type 5 subunit alpha (isoform a) | Sodium voltage-gated channel alpha subunit 5, transcript variant 2 | Sodium channel protein cardiac muscle subunit alpha | CDCD2 | Sodium channel protein type 5 subunit alpha | CMD1E | SCN5A_HUMAN | ICCD | Voltage-gated sodium channel subunit alpha Nav1.5 | HB2 | Nav1.5 | SCNA5A | Sodium voltage-gated channel alpha subunit 5, transcript variant 1 | VF1 | LQT3 | SCN5A variant 1 | sodium channel protein cardiac muscle subunit alpha | Sodium channel protein type 5 subunit alpha (isoform c) | hH1 | Sodium voltage-gated channel alpha subunit 5, transcript variant 6 | Cardiac tetrodotoxin-insensitive voltage-dependent sodium channel alpha subunit | HH1 | SCN5A variant 3 | Sodium channel protein type V subunit alpha | CMPD2 | HBBD | sodium channel, voltage-gated, type V, alpha subunit | voltage-gated sodium channel subunit alpha Nav1.5 | Sodium voltage-gated channel alpha subunit 5, transcript variant 4 | SCN5A variant 6 | SCN5A (Nav1.5)

SCN5A: A GPCR Involved in Neurotransmitter Signaling and Ion Channel Regulation

SCN5A, or Nicotinamide dinucleotide (NDI) receptor subfamily G member 5A, is a protein that is expressed in various tissues throughout the body, including the nervous system, endocrine system, and gastrointestinal tract. It is a G protein-coupled receptor (GPCR), which means that it interacts with protein molecules called GPCRs, which are found throughout the cell surface of the cell. GPCRs are involved in a wide range of physiological processes in the body, including sensory perception, neurotransmitter signaling, and hormone regulation.

The SCN5A protein is best known for its role in neurotransmitter signaling, particularly the neurotransmitter serotonin. Serotonin is a chemical that is involved in the regulation of mood, appetite, and sleep, among other things. It is produced by the body's own production system, but it can also be synthesized in the brain and used as a drug target.

SCN5A is a receptor that is involved in the signaling of serotonin. It is a GPCR that is primarily expressed in the brain and spinal cord, and it is thought to play a key role in the regulation of serotonin levels in the brain. It is also involved in the regulation of other neurotransmitters, including dopamine and GABA.

One of the key functions of SCN5A is its role in the regulation of serotonin levels. It is thought to play a key role in the uptake and storage of serotonin in the brain, as well as its release. This is important for the regulation of mood, as changes in serotonin levels can cause symptoms such as anxiety and depression.

In addition to its role in serotonin regulation, SCN5A is also involved in the regulation of other neurotransmitters. It is thought to play a key role in the regulation of dopamine levels, which are involved in motor movement and mood regulation. It is also involved in the regulation of GABA levels, which is a neurotransmitter that is involved in the inhibition of muscle activity and the regulation of sleep.

SCN5A is also involved in the regulation of ion channels in the brain. This is important for the regulation of electrical activity in the brain, which is critical for the function of the brain.

In addition to its role in neurotransmitter regulation, SCN5A is also involved in the regulation of other physiological processes in the body. It is thought to play a key role in the regulation of blood pressure, as well as the regulation of bone density.

Despite its importance for a wide range of physiological processes, SCN5A is not yet a drug target. There is ongoing research into the potential uses of SCN5A as a drug target, particularly for the treatment of anxiety and depression.

One of the main advantages of SCN5A as a drug target is its expression in the brain and spinal cord. This makes it a promising target for drugs that can affect the levels of serotonin in the brain. Additionally, SCN5A is a GPCR, which means that it is a type of receptor that can be targeted by small molecules, which makes it a more attractive target than some other protein targets.

Another potential advantage of SCN5A is its role in the regulation of other neurotransmitters. This suggests that it may be involved in the regulation of a wide range of neurotransmitters, which could make it a useful target for drugs that affect neurotransmitter levels. Additionally, the fact that SCN5A is involved in the regulation of ion channels in the brain suggests that it may be a useful target for drugs that affect ion channels and neurotransmitter regulation.

In conclusion, SCN5A is a protein that is expressed in various tissues throughout the body, including the nervous system, endocrine system, and gastrointestinal tract. It is a GPCR that is involved in

Protein Name: Sodium Voltage-gated Channel Alpha Subunit 5

Functions: This protein mediates the voltage-dependent sodium ion permeability of excitable membranes. Assuming opened or closed conformations in response to the voltage difference across the membrane, the protein forms a sodium-selective channel through which Na(+) ions may pass in accordance with their electrochemical gradient (PubMed:1309946, PubMed:21447824, PubMed:25370050, PubMed:23420830, PubMed:23085483, PubMed:26279430, PubMed:26392562, PubMed:26776555). It is a tetrodotoxin-resistant Na(+) channel isoform (PubMed:1309946). This channel is responsible for the initial upstroke of the action potential. Channel inactivation is regulated by intracellular calcium levels (PubMed:19074138)

More Common Targets

SCN7A | SCN8A | SCN9A | SCNM1 | SCNN1A | SCNN1B | SCNN1D | SCNN1G | SCO1 | SCO2 | SCOC | SCOC-AS1 | SCP2 | SCP2D1 | SCP2D1-AS1 | SCPEP1 | SCRG1 | SCRIB | SCRN1 | SCRN2 | SCRN3 | SCRT1 | SCRT2 | SCT | SCTR | SCUBE1 | SCUBE2 | SCUBE3 | SCXA | SCYL1 | SCYL2 | SDAD1 | SDAD1-AS1 | SDAD1P1 | SDC1 | SDC2 | SDC3 | SDC4 | SDCBP | SDCBP2 | SDCBP2-AS1 | SDCBPP2 | SDCCAG8 | SDE2 | SDF2 | SDF2L1 | SDF4 | SDHA | SDHAF1 | SDHAF2 | SDHAF3 | SDHAF4 | SDHAP1 | SDHAP2 | SDHAP3 | SDHAP4 | SDHB | SDHC | SDHD | SDHDP1 | SDHDP2 | SDK1 | SDK1-AS1 | SDK2 | SDR16C5 | SDR16C6P | SDR39U1 | SDR42E1 | SDR42E2 | SDR9C7 | SDS | SDSL | SEBOX | SEC11A | SEC11B | SEC11C | SEC13 | SEC14L1 | SEC14L1P1 | SEC14L2 | SEC14L3 | SEC14L4 | SEC14L5 | SEC14L6 | SEC16A | SEC16B | SEC1P | SEC22A | SEC22B | SEC22C | SEC23A | SEC23B | SEC23IP | SEC24A | SEC24AP1 | SEC24B | SEC24B-AS1 | SEC24C | SEC24D | SEC31A